Shinya Kaname Selected Research

K 130

1/2020

Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shinya Kaname Research Topics

Disease

6	Glomerulonephritis 08/2022 - 04/2010
5	Vasculitis (Vasculitides) 08/2022 - 02/2022
5	Infections 07/2022 - 08/2008
5	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2022 - 10/2013
4	Chronic Kidney Failure (Chronic Renal Failure) 05/2022 - 01/2003
4	Proteinuria 01/2020 - 04/2010
4	Fever (Fevers) 07/2019 - 01/2011
3	Microscopic Polyangiitis 04/2022 - 11/2013
3	Autosomal Dominant Polycystic Kidney (ADPKD) 02/2022 - 01/2020
3	Hematuria 11/2013 - 01/2011
2	Arthritis (Polyarthritis) 10/2022 - 01/2020
2	Chronic Renal Insufficiency 07/2022 - 12/2014
2	COVID-19 05/2022 - 02/2022
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 04/2022 - 11/2013
2	Membranous Glomerulonephritis (Membranous Nephropathy) 01/2021 - 01/2011
2	Inflammation (Inflammations) 01/2020 - 09/2009
2	Exanthema (Rash) 01/2020 - 07/2019
2	Atypical Hemolytic Uremic Syndrome 01/2019 - 01/2019
2	Thrombotic Thrombocytopenic Purpura 01/2019 - 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022
1	Drug-Related Side Effects and Adverse Reactions 07/2022
1	Cardio-Renal Syndrome 07/2022
1	Lymphoma (Lymphomas) 07/2022
1	Neoplasms (Cancer) 07/2022
1	Urinary Tract Infections (Urinary Tract Infection) 07/2022
1	Nephritis 06/2022
1	Rare Diseases (Rare Disease) 06/2022
1	Systemic Vasculitis 06/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Sacroiliitis 01/2021
1	Non-Radiographic Axial Spondyloarthritis 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Hyperplasia 01/2021
1	Behcet Syndrome (Behcet's Syndrome) 08/2020
1	Syphilis 01/2020
1	Oliguria 01/2020
1	Disease Progression 01/2020
1	Conjunctivitis 01/2020
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2020
1	Urethritis 01/2020
1	Human Influenza (Influenza) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Adult-Onset Still's Disease 07/2019
1	Pharyngitis (Sore Throat) 07/2019
1	Arthralgia (Joint Pain) 07/2019

Drug/Important Bio-Agent (IBA)

9	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2022 - 01/2011
6	Peroxidase (Myeloperoxidase)IBA 08/2022 - 01/2011
3	CreatinineIBA 07/2022 - 12/2014
3	Antigen-Antibody Complex (Immune Complex)IBA 06/2022 - 04/2013
3	Tolvaptan FDA Link 02/2022 - 01/2020
3	Immunoglobulin G (IgG)IBA 01/2021 - 01/2011
3	C-Reactive ProteinIBA 01/2020 - 11/2013
2	antiglomerular basement membrane antibodyIBA 06/2022 - 01/2020
2	AntibodiesIBA 05/2022 - 10/2013
2	SteroidsIBA 01/2021 - 11/2013
2	Proteins (Proteins, Gene)FDA Link 11/2019 - 04/2010
2	eculizumab FDA Link 01/2019 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2018 - 04/2005
2	AlbuminsIBA 12/2014 - 04/2005
2	Messenger RNA (mRNA)IBA 04/2010 - 04/2005
2	oxidized low density lipoproteinIBA 01/2003 - 10/2000
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 10/2022
1	Valganciclovir FDA Link 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2022
1	Combined Antibody TherapeuticsIBA 05/2022
1	casirivimab and imdevimab drug combinationIBA 05/2022
1	Neutralizing AntibodiesIBA 05/2022
1	avacopanIBA 04/2022
1	Prednisone (Sone)FDA LinkGeneric 04/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Reticulin (Reticular Fiber)IBA 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Thrombopoietin ReceptorsIBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	TEMPOIBA 09/2020
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 08/2020
1	LactoferrinIBA 08/2020
1	4-O-carboxymethylascochlorinIBA 01/2020
1	streptolysin OIBA 01/2020
1	GlucocorticoidsIBA 01/2020
1	Antinuclear AntibodiesIBA 01/2020
1	Rheumatoid FactorIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	K 130IBA 01/2020
1	Ferritins (Ferritin)IBA 07/2019

Therapy/Procedure

10	Therapeutics 06/2022 - 09/2009
2	Drug Therapy (Chemotherapy) 07/2022 - 01/2021
2	Plasmapheresis 06/2022 - 01/2021
2	Plasma Exchange 06/2022 - 01/2020
2	Renal Dialysis (Hemodialysis) 05/2022 - 01/2021
2	Peritoneal Dialysis 08/2008 - 05/2006
1	Hematopoietic Stem Cell Transplantation 07/2022
1	Renal Replacement Therapy (Therapies, Renal Replacement) 07/2022
1	Kidney Transplantation 07/2022
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2020